If confinement measures implemented in China and South Korea seem to be working to fight against the propagation of the coronavirus, the number of people infected by COVID-19 in the rest of the world keeps on rising. So, to face this world’s health crisis, searchers and health professionals have been working hard to try and find an effective medication to erase COVID-19. If the vaccine may not be used for several months, clinical trials are currently carried out in some places of the globe.
Hydroxychloroquine, Dexamethasone, Tocilizumab, blood plasma, Anakinra... As many potentially effective treatments doctors from all around the world test on patients at different stage of the disease within clinical trials. And if you do not know where to start with all these tests and vaccine prototypes, we give you a list of treatments and vaccines currently studied to have a big picture of the current research works.
Vaccines studied in the world:
Coronavirus: Russia announces two new vaccines are being tested on volunteers
Research against coronavirus continues! The Russian health minister announced this Wednesday June 17, 2020 to launch clinical trials for two prototypes of vaccines on 76 volunteers infected by Covid-19. Results highly awaited.
Coronavirus: France teams up with three other European countries to purchase vaccines
In order to fight against the Covid-19 pandemic as well as possible, France has teamed up with Germany, the Netherlands, and Italy within Europe’s Inclusive Vaccines Alliance. Together, they announce to have signed a first principle agreement with the AstraZeneca laboratory to buy several millions of vaccine doses.
Coronavirus: Moderna Therapeutics vaccine already delivers encouraging results
The fight against coronavirus is speeding up! American laboratory Moderna has announced “positive interim data” for the first phase of the clinical trial conducted on a small number of volunteers. A clinical trial with interesting results, causing an encouraging immune response for the rest.
Coronavirus: clinical studies for the vaccine against Covid-19 quicker than expected?
Institut Pasteur scientifc head Christophe Denfert was invited this Sunday April 5 on France Info. He was really positive as for the current research for a vaccine against coronavirus, explaining clinical trials could happen quicker than expected.
Coronavirus: the research for a vaccine is speeding up
To fight against coronavirus, laboratories are working even harder to find a vaccine and this is what may have discovered scientists from the University Pittsburgh School of Medicine. Where’s the research is at today? Let’s have a look on breakthrough and other promising discoveries.
Treatments under clinical trial:
Coronavirus: chloroquine use subject to a control
Currently into lockdown in France, the medical staff keeps fighting against coronavirus, and a cure based on chloroquine is at the heart of the debate. This Monday March 23rd, 2020, Olivier Véran announces to supervise the medication as a cure to Covid-19.
Coronavirus: the European Union allows putting Remdesivir on the market
Remdesivir is at the heart of research against coronavirus and has been adopted in the United-States in early May. The European Union is now validating the authorization to put the treatment on the market.
Coronavirus: the lopinavir/ritonavir cocktail ineffective, the Recovery trail says
Is the lopinavir/ritonavir blend to fight against coronavirus ineffective? This is what several leaders of the Recovery trial say.
Coronavirus: does chlorpromazine, medication against bipolarity, protect against COVID-19?
Medication against bipolarity, chlorpromazine could protect yourself against coronavirus. According to the Sainte-Anne University Hospital, patients treated with chlorpromazine are less hit by COVID-19 and symptomatic cases are rare. The Institut Pasteur has just launched a study.
Coronavirus: Anakinra, a promising treatment?
Is Anakinra an effective treatment against coronavirus? According to a French study released in The Lancet, the medicine usually prescribed for rheumatic diseases released encouraging results on severe Covid-19 forms. First results that will have to be confirmed on a greater number of patients.
Coronavirus: Tocilizumab, "a serious lead" but "without enough back up" Olivier Véran says
The AP-HP has just revealed the first results of the clinical trial carried out in 13 hospitals in France on the use of Tocilizumab, a medication generally used in rheumatology in order to lower the number of patients in ICU. First results are promising.
Coronavirus: plasma transfusions effective against the disease
Chinese searchers have released a study proving the effectiveness of plasma transfusion in severe coronavirus patients. Hope for many patients across the globe, while waiting for a vaccine.